Proteomic characterisation of perhexiline treatment on THP-1 M1 macrophage differentiation
BackgroundDysregulated inflammation is important in the pathogenesis of many diseases including cancer, allergy, and autoimmunity. Macrophage activation and polarisation are commonly involved in the initiation, maintenance and resolution of inflammation. Perhexiline (PHX), an antianginal drug, has b...
Main Authors: | Bimala Dhakal, Celine Man Ying Li, Mahnaz Ramezanpour, Ghais Houtak, Runhao Li, George Bouras, Alex Collela, Nusha Chegeni, Tim Kennion Chataway, Paul Drew, Benedetta C. Sallustio, Sarah Vreugde, Eric Smith, Guy Maddern, Giovanni Licari, Kevin Fenix |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1054588/full |
Similar Items
-
Prophage: a crucial catalyst in infectious disease modulation
by: Roshan Nepal, et al.
Published: (2022-03-01) -
Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis
by: Jun Li, et al.
Published: (2023-04-01) -
Perhexiline: Old Drug, New Tricks? A Summary of Its Anti-Cancer Effects
by: Bimala Dhakal, et al.
Published: (2023-04-01) -
Is Short-Read 16S rRNA Sequencing of Oral Microbiome Sampling a Suitable Diagnostic Tool for Head and Neck Cancer?
by: Kenny Yeo, et al.
Published: (2024-09-01) -
Cytokine-Induced Modulation of SARS-CoV2 Receptor Expression in Primary Human Nasal Epithelial Cells
by: Mahnaz Ramezanpour, et al.
Published: (2021-07-01)